BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26469169)

  • 1. [Complete Response in Far-Advanced Esophageal Cancer Treated with Induction Chemotherapy Followed by Definitive Chemoradiotherapy].
    Kaburagi T; Harada H; Koizumi W; Aga K; Watanabe H; Seki H; Yasui N; Sakata M; Matsumoto H; Shimada A
    Gan To Kagaku Ryoho; 2015 Sep; 42(9):1103-6. PubMed ID: 26469169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Three-Year Survival after Lymphadenectomy for Residual Lymph Node Metastasis of Esophageal Cancer with Invasion into the Trachea and Carotid Artery after Chemoradiotherapy - A Case Report].
    Odagiri K; Yamazaki M; Tanaka K; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Nakajima K; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):2006-2008. PubMed ID: 29394849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of advanced esophageal cancer with multiple lymph node metastases successfully treated with induction chemotherapy consisting of nedaplatin and 5-FU followed by chemoradiotherapy].
    Sasaki T; Nakamura K; Toba T; Kimura M; Ohga S; Urashima Y; Terashima H; Masuda K
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1417-20. PubMed ID: 12214470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of advanced esophageal cancer with liver metastases: efficacy of combination therapy of docetaxel/cisplatin/5-FU].
    Ehara K; Tsutsumi K; Kinoshita Y; Ueno M; Mine S; Udagawa H
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1375-8. PubMed ID: 18701852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complete response in a case of advanced esophageal cancer infiltrating into the main bronchus treated by chemoradiation therapy].
    Tsukao Y; Yamazaki M; Miyazaki Y; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2124-6. PubMed ID: 24394034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of multiple advanced esophageal carcinomas with abdominal LN metastases showing complete response after chemoradiotherapy with concurrent cisplatin, 5-FU and adriamycin chemotherapy].
    Yasuda T; Yano M; Takiguchi S; Kimura Y; Fujiwara Y; Monden M
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1737-40. PubMed ID: 14619507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of residual metastatic lymph node lesion following definitive chemoradiotherapy for T4 esophageal cancer, successfully treated by outpatient clinic-based sequential chemotherapy with docetaxel followed by S-1].
    Yoneda M; Fujiwara H; Shiozaki A; Komatsu S; Ichikawa D; Okamoto K; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Ochiai T; Kokuba Y; Otsuji E
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2397-400. PubMed ID: 22202394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-Term Complete Response in Postoperative Multiple Lung and Mediastinal Lymph Node Metastases of Esophageal Cancer Using Systemic Chemotherapy with DCF Treatment - A Case Report].
    Katsumi C; Bamba T; Nakagawa S; Aizawa M; Matsuki A; Yabusaki H; Homma K
    Gan To Kagaku Ryoho; 2017 Jan; 44(1):75-78. PubMed ID: 28174385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Local or Metastatic Esophageal Cancer.
    Iwasaki K; Osaka Y; Tachibana S; Suda T; Ota Y; Hoshino S; Tsuchida A
    Anticancer Res; 2016 Mar; 36(3):987-94. PubMed ID: 26976988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of advanced esophageal cancer invaded to the trachea with PCR after preoperative chemoradiotherapy, which relapsed at the time of three years and seven months after resection].
    Kawasaki H; Wajima N; Miyamoto K; Maruyama A; Takahashi K; Kubo N; Hakamada K
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2388-90. PubMed ID: 22202391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus.
    Gkika E; Gauler T; Eberhardt W; Stahl M; Stuschke M; Pöttgen C
    Dis Esophagus; 2014; 27(7):678-84. PubMed ID: 24147973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Case of Advanced Esophageal Cancer Successfully Treated with DCF Chemotherapy Followed by Conversion Surgery].
    Okada K; Takeoka T; Miki H; Kobayashi K
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1623-1625. PubMed ID: 29394722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of advanced esophageal cancer patient surviving more than 7 years treated with chemoradiotherapy].
    Kubo N; Kawasaki H; Takahashi K; Maruyama M; Miyamoto K; Wajima N; Hakamada K
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2385-7. PubMed ID: 22202390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial of induction epirubicin, oxaliplatin, and fluorouracil, followed by surgery and postoperative concurrent cisplatin and fluorouracil chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus and gastroesophageal junction.
    McNamara MJ; Adelstein DJ; Bodmann JW; Greskovich JF; Ives DI; Mason DP; Murthy SC; Rice TW; Saxton JP; Sohal D; Stephans K; Rodriguez CP; Videtic GM; Rybicki LA
    J Thorac Oncol; 2014 Oct; 9(10):1561-7. PubMed ID: 25170643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.
    Haddad R; O'Neill A; Rabinowits G; Tishler R; Khuri F; Adkins D; Clark J; Sarlis N; Lorch J; Beitler JJ; Limaye S; Riley S; Posner M
    Lancet Oncol; 2013 Mar; 14(3):257-64. PubMed ID: 23414589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple induction chemotherapy and chemoradiotherapy for locally advanced esophageal cancer. A phase II study.
    Eisterer W; DE Vries A; Kendler D; Spechtenhauser B; Königsrainer A; Nehoda H; Virgolini I; Lukas P; Bechter O; Wöll E; Ofner D
    Anticancer Res; 2011 Dec; 31(12):4407-12. PubMed ID: 22199307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of advanced esophageal cancer revealed a pathological complete response and survived more than 8 years, treated by radiation therapy combined with nedaplatin and 5-FU chemotherapy].
    Kubo H; Nakasuga C; Tada K; Miyahara M; Hasegawa H; Kondo S; Yamashita Y
    Gan To Kagaku Ryoho; 2013 Sep; 40(9):1209-11. PubMed ID: 24047781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of concurrent chemoradiotherapy combined with a weekly paclitaxel and 5-fluorouracil regimen to treat patients with advanced oesophageal carcinoma.
    Xia Y; Li YH; Chen Y; Zhang JH; Liu Q; Deng JY; Ai TS; Zhu HT; Fan JH; Badakhshi H; Zhao KL
    Radiat Oncol; 2017 Mar; 12(1):47. PubMed ID: 28270162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of stage IV (N4) esophageal cancer successfully treated with concurrent chemoradiotherapy].
    Tsuchiyama T; Maeda H; Iida A; Fujita T; Kobayashi T; Katayama SK; Hirose K; Yamaguch A; Nakagawara G
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1965-8. PubMed ID: 9797821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.